Status
Conditions
About
A prospective, multi-center, non-interventional cohort study is going to conduct to explore the clinical characteristics, culprit drug(s) or herb(s), outcomes and risk factors of Drug-induced liver injury (DILI) in China and screen novel serum markers.
A prognostic model incorporating with the novel serum marker(s) for DILI would be established and validated to imporve the prognosis of patients in China .
Full description
Research Objectives:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
3,000 participants in 2 patient groups
Loading...
Central trial contact
Zikun Ma; Yan Wang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal